Remission Rate of Newly Diagnosed Type 2 Diabetes Outpatients Treated With Short-term Intensive Insulin Therapy

NCT03030300 Phase 4 COMPLETED

To evaluate the long-term remission rate of short-term intensive insulin (STII) therapy in newly diagnosed type 2 diabetes outpatients and investigate the predictors contributing to the remission rate.

Details

Lead sponsor	Qianfoshan Hospital
Phase	Phase 4
Status	COMPLETED
Enrolment	170
Start date	2008-01
Completion	2015-02

Conditions

• Type2 Diabetes

Interventions

• Novolin 30R;Pioglitazone;Metformin

Primary outcomes

• prolonged-remission rate — 5 years
  hyperglycemia below diagnostic thresholds for diabetes without active pharmacologic therapy or ongoing procedures of 5 years' duration.
• partial-remission rate — 5 years
  hyperglycemia below diagnostic thresholds for diabetes without active pharmacologic therapy or ongoing procedures of more than 3 months' duration, and less than 5 years.

Countries

China